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A heat-stable enterotoxin produced by a strain of enterotoxigenic Escherichia coli 18D was purified by ion- 
exchange and reversed-phase high-pressure liquid chromatography. The amino acid sequence of the 
purified toxin was determined by Edman-degradation and a combination of fast atom bombardment mass 
spectrometry and carboxypeptidase digestion to be Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro- 
Ala-Cys-Ala-Gly-Cys-Tyr. 
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1. INTRODUCTION 
Enterotoxigenic Escherichia coli (ETEC) pro- 
duces at least two types of enterotoxins that cause 
diarrhea1 disease in man and various domestic 
animals: low-M,, heat-stable nterotoxin (ST), and 
high%r, heat-labile enterotoxin (LT) [l]. It was 
recently confirmed [2,3] that there are two 
genetically distinct ST’s, which were named STIa 
and STIb. The DNA sequences encoding STIa and 
STIb were determined in [3] and [4], respectively. 
Since STIa and STIb originated from porcine and 
human strains of ETEC, we here designate them as 
ST, and STI,, respectively. 
Recently, we isolated and purified STh from 
ETEC of human patients [5,6] and determined its 
amino acid sequence of 19 amino acid residues [6]. 
The sequence was different from that deduced 
from the DNA sequence encoding ST,, but iden- 
tical to that deduced from the DNA sequence of 
STh, except for the C-terminal amino acid residue. 
In [7] the amino acid sequence of an ST isolated 
from an ETEC strain 18D, was not similar to that 
* To whom correspondence should be addressed 
of STh but was similar to that deduced from the 
DNA sequence of ST,, although the strain was 
derived from human patients. However, strain 
18D was found by the DNA hybridization techni- 
que to be a strain producing ST, (P. Echeverria, 
personal communication). 
Here, we describe the isolation of an ST (= ST,) 
from ETEC strain 18D and its sequence determina- 
tion by Edman-degradation and a combination of 
fast atom bombardment (FAB) mass spectrometry 
and carboxypeptidase digestion [8,9]. 
2. MATERIALS AND METHODS 
2.1. Bacterial strain and culture conditions 
E. coii 18D, kindly given by Dr Giannella 
(University of Cincinnati, OH), was used 
throughout. The cells were grown in CAYE 
medium [lo] at pH 8.6 without glucose at 37°C for 
24 h with vigorous shaking, as in [5]. 
2.2. Isolation of the toxin 
Crude toxin was extracted from the culture 
filtrate (20 L), as in [5]. The crude toxin was chro- 
matographed successively on SP-Sephadex C-50 
(H+ form) and DEAE-Sephadex A-25 (acetate 
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form) as in [6]. In each case, the main fraction with 
biological activity was collected for further 
purification. Final purification was achieved by 
reversed-phase HPLC on a LiChrosorb RP-8 col- 
umn under the conditions described in the legend 
to fig.3. 
2.3. Biological assay 
ST activity was assayed in suckling mice of 2-4 
days old, as in [5]. The fluid accumulation ratio of 
each animal was calculated as the ratio of the 
weight of the entire intestine to that of the rest of 
the body. The minimal amount of ST giving a fluid 
accumulation ratio of over 0.09 was designated as 
1 mouse unit (MU), as in [5]. 
2.4. Amino acid analysis 
Purified toxin and its derivatives were hydrolyz- 
ed in 4 M methane-sulfonic acid for 24 h at 105°C 
in vacuum-sealed tubes and the hydrolysates were 
analyzed in a Hitachi type 835 analyzer. 
2.5. Aminoethylation and carboxymethylation 
Samples of 685 pg (-348 nmol) and 550,ug 
(-280 nmol) of native ST, were reduced and then 
aminoethylated and carboxymethylated, respec- 
tively, as in [6]. The recoveries of aminoethylated 
ST, and carboxymethylated ST, were 540 ,ug and 
3 10 pg, respectively. 
2.6. Enzymatic digestion 
Aminoethylated ST,, (540 pg, -242 nmol) was 
dissolved in 0.5% NHdHC03 (640,ul) with pro- 
tease V8 (EC 3.4.21.19) (16 pg in 8 ~1). The mix- 
ture was deaerated in a stream of nitrogen and kept 
at 37°C for 18 h. The digest was lyophilized 
repeatedly, and then the lyophilizate (405 pg) was 
dissolved in 0.1 M pyridine acetate (pH 8.0; 45 ~1) 
and treated with carboxypeptidase B (EC 3.4.17.2) 
(8 pg) at room temperature. Aliquots were 
withdrawn from the digest at appropriate times for 
mass measurement. 
2.7. Edman degradation 
Carboxymethylated ST, (155 ,ug, -66.7 nmol) 
was degraded manually [ 111. 
2.8. FAB mass spectrometry 
Mass spectra were recorded with a Jeol double- 
focusing mass spectrometer JMS-HXlOO equipped 
2 
with a high-magnetic field and an FAB ion source. 
The sample (40-50 pg) was dissolved in 1 M HCl 
(1 rl), mixed with glycerol (3 pl), and applied to a 
stainless steel sample holder (3 x 3 mm). Typical 
experimental conditions were as follows: xenon 
atom beam source, 3 KeV accelerating potential 
and 200 ,uA emission current. Ion source, 5 KV ac- 
celerating potential. 
3. RESULTS AND DISCUSSION 
3.1. Purification 
Crude toxin extracted from the culture superna- 
tant of E. coli 18D was chromatographed on SP- 
Sephadex C-50 (fig. 1). The main toxic activity was 
recovered in a peak eluted with 0.1 M AcONH4 
(pH 6.6). Since the peak fraction still contained a 
large amount of pigmented material, the area 
shown by a horizontal bar was then subjected to 
ion-exchange chromatography on DEAE- 
Sephadex A-25. The toxic activity emerged in the 
area shown by a horizontal bar in fig.2. Final 
purification was performed by HPLC on a 
reversed-phase column, as shown in fig.3. The 
main toxic fraction shown by a horizontal bar was 
confirmed to be pure by repeated HPLC (not 
shown). The purification of ST, is summarized in 
table 1. The amino acid composition was determin- 
ed to be Asp2.01 W, Thro.99 (I), Gh.16 (I), R-01.27 
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Fig.1. Chromatography on SP-Sephadex C-50 of crude 
toxin. Column size: 3 x 46 cm, H+ form. Elution: An 
aqueous solution of crude toxin was applied, the column 
was washed with dist. water and then material was 
eluted with 0.1 M AcONH4 (pH 6.7). Fractionation size: 
13.5 ml/tube: flow rate: 150 ml/h. 
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I I_-. Table 1 
Fraction Number 
Fig.2. Chromatography on DEAE-Sephadex A-25 of the 
fraction shown by a horizontal bar in fig. 1. Column size: 
1.2 x 53 cm, acetate form. Elution: a linear gradient 
from Hz0 to 0.32 M AcOH and then 1 M HCOOH. 
Fractionation size: 13.5 ml/tube; flow rate: 75 ml/h. 
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Fig.3. Reversed-phase HPLC of the toxic fraction ob- 
tained by DEAE-Sephadex A-25 chromatography (fig.2). 
Column: LiChrosorb RP-8 (8 x 300 mm, 5 am). Elution: 
sample (tube no.54 in fig.2) was applied and material 
was efuted with 10% CH$ZN in0.01 M AcONH4 (pH 5.7) 
for 10 min and then with a linear gradient (----) of 
lo-35% CHsCN in 0.01 M AcON& (pH 5.7). Flow 
rate: 2 ml/mitt. The toxic activity was found in the peak 
marked by a horizontal bar. 
(1h GhI6 (1), Alwoo (21, xcys4.92 (61, LeIU 
(l), Tyrr.92 (2), and Pheo.99 (1) (values were 
calculated as mol/mol of Ala; numbers in paren- 
theses indicate nearest integer values). The values 
were identical to those of the ST in 1121. The 
minimum effective dose of purified ST,, in suckling 
mice assay was 2.5 ng. 
Summary of purification of ST, produced by 
ETEC 18D 
Total unit Spec.act. Recovery 
@g/MU) (Too) 
Culture supernatant 
(20 L) 3.2 x lo6 17800 100 
Crude toxin 2.48 x IO6 224 77.5 
SP-Sephadex C-50 1.89 x lo6 172 59.1 
DEAE-Sephadex A-25 4.05 x 10’ 12.7 
HPLC 2.5 (1.49 mg) 
3.2. &&-value 
Purified ST, was analyzed by FAB mass spec- 
trometry, a method developed in [13] and the 
results are shown in fig.4. The observed signal at 
m/z = 1971 indicated that the iK of ST, was 1970, 
because free peptides generally give protonated 
molecular ions ([M f HI+, where M denotes the 
MJ in positive FAB mass spectra. This &value 
was compatible with the M, (1969- 1972) calculated 
from the amino acid composition (Asp + Asn and 
Glu + Gln were analyzed as Asp and Glu, respec- 
tively, in the acid hydrolysate). 
3.3. Amino acid sequence 
Recently, we attempted to synthesize ST with the 
amino acid sequence reported in [7] and found that 
the synthetic peptide had a different retention time 
on HPLC from that of the native toxin isolated 
from the same strain ETEC 18D as that used in 
[ 121. This finding suggested that the purified native 
toxin used in our work had a different amino acid 
sequence from that proposed in [7], although it 
had the same amino acid composition as that of 
their proposed sequence. 
Some of us [8,9] recently developed a new 
method for sequence determination of peptide 
mixtures by a combination of field-desorption 
(FD) mass spectrometry and exopeptidase diges- 
tion. We used this method for determination of the 
sequence of ST,, but with FAB mass spectrometry 
instead of FD mass spectrometry [6,14]. FigSA 
shows the positive FAB mass spectrum of reduced 
and aminoethylated ST, digested with protease V8, 
giving intense signals at m/z = 965 and 1289. The 
3 
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Fig.4. Positive FAB mass spectrum of purified ST,. 
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Fig.5. Positive FAB mass spectra of: (A) aminoethylated (AE) ST, digested with protease V8; (B) a mixture of samples 
of (A) treated with carboxypeptidase B for 30 s, 1 and 5 min. 
results suggest that the resulting two peptide 
fragments had M, of 964 and 1288. Fig.SB shows 
the positive FAB mass spectrum of the digest with 
carboxypeptidase B of the peptide fragments 
shown in fig.SA. From the observed signals at 
m/z = 980 and 1126, the C-terminus of the peptide 
fragment with the mass value 1289 was - 
Cys(AE)( 146)-Tyr( 163)-OH (where AE means an 
aminoethyl group and numbers in parentheses 
denote residual weights of amino acids). The FD 
mass spectrum of the carboxypeptidase B digest 
gave intense signals at m/z = 165 and 182 together 
with 1126 (not shown), indicating that aminoethyl- 
4 
cysteine (165) and tyrosine (182) were released 
from the peptide fragment (1289). 
Reduced and carboxymethylated ST, was 
degraded manually by the Edman method, the 
results revealed the sequence of 16 amino acid 
residues from the N-terminus. At the C-terminal 
two residues were uncertain. The sequence was 
compatible with the data obtained from the mass 
spectra shown in fig.4,5A and 5B. The sequence 
data are summarized and compared with reported 
sequences for ST in fig.6. 
In conclusion, the primary structure of ST, was 
established. As shown in fig.6, the sequence was 
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Fig.6. Amino acid sequence of ST: (a) present data: - 
Edman method, - a combination of FAB mass spectro- 
metry and carboxypeptidase B digestion and A4, of 
aminoethylated STP, digested with protease V8; (b) see 
[7]; (c) see [3]; (d) see [6]. 
identical to that deduced from the DNA sequence 
encoding ST, [3], but different from that proposed 
in [7]. In addition, common and different struc- 
tural features of ST, and STh [6] were established. 
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